Related Experiment Video
Updated: Jan 15, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Next-Generation ADC Design and Innate Immune Modulation: Emerging Strategies for Potent Cancer Therapy and Systemic
Anna C Renner1, Robert B Kargbo2
1North Dakota State University, Fargo, North Dakota 58108-6050, United States.
Abstract:
Recent innovations in ADC design and innate immune modulation reveal complementary therapeutic strategies for cancer and inflammatory diseases. Novel hydrophilic multivalent linkers enable very high drug-to-antibody ratios and dual-payload ADCs, while modulation of MDAS, TLR7, TLR5, and STING pathways induces p16+ immune subsets that promote disease tolerance. Together, these inventions highlight convergent mechanisms for improving efficacy, resilience, and therapeutic durability.
Related Concept Videos
Tumor Immunotherapy
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cell-mediated Immune Responses
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

